30988 research outputs found
Sort by
Maskuliinisen miehen raskas rooli: Mieheyden biopoliittinen haltuunotto Tony Halmetta käsittelevässä julkisessa keskustelussa 2020-luvulla
Tony Halme (s. 1963, k. 2010) asettui perussuomalaisten sitoutumattomaksi ehdokkaaksi vuoden 2003 eduskuntavaaleissa kampanjalla, joka suhtautui vihamielisesti humanitääriseen maahanmuuttoon, sosiaalivaltioon ja feminismiin. Halmeen eduskuntavaalikampanja on toistuvasti nähty käännekohtana oikeistopopulismin valtavirtaistumisessa Suomessa. Tarkastelen tässä artikkelissa Tony Halmeen julkista muistamista ja siinä ilmeneviä määrittelykamppailuja 2020-luvulla. Aineisto koostuu 31 lehtikirjoituksesta. Analyysin perusteella tunnistetaan neljä affektiivis-diskursiivisia kaanonia eli säännönmukaista tunteenilmauksista ja merkityksellistämisen tavoista koostuvaa muodostelmaa. Ensinnäkin Halmeesta rakennettiin sympatiaa ansaitseva kaltoinkohtelun uhri, johon vaikuttivat miehiin kohdistuneet epäterveet odotukset. Tämä sympatia ulotettiin myös Halmeen kannattajiin, joiksi määrittyivät suomalaisessa sosiaalipolitiikassa syrjään jääneet nuoret miehet. Näihin puhetapoihin kohdistui vastustusta. Toisinaan miehet tunnistettiin vihamielisestä toiminnastaan vastuullisiksi toimijoiksi ja Halmeen sympatisointiin kohdistettiin inhoa ja ivaa. Lisäksi Halmeesta hyötyneeseen oikeistopopulistiseen liikehdintään suhtauduttiin toistuvasti vieroksuen silloin, kun sitä ei tarkasteltu poikahuolen ja miesten tasa-arvo-ongelmien kontekstissa. Esitän, että Halmetta koskevassa julkisessa keskustelussa harjoitettiin sekä mieheyden biopoliittista haltuunottoa että kritisoitiin laajamittaista mieheyteen puuttumisen tarvetta vedoten yksilöiden vastuuseen itsestään. Määrittelykamppailun osapuolten jaettu päämäärä oli sukupuolijoustava, väkivaltaisesta nationalismista irrallinen ja työmarkkinoihin sitoutunut mieheys
The State’s Positive Obligation to Ensure Accessibility for the Realization of Equality of Persons with Disabilities
Resilience as Adaptive Deterrence in an Era of Strategic Uncertainty
This volume examines the strategic transformation of NATO’s borderland regions from perceived vulnerabilities to recognised strategic assets within the Alliance’s collective defence architecture. Since Russia’s full-scale invasion of Ukraine in February 2022, the European security landscape has undergone profound changes, exposing limitations of traditional deterrence models and necessitating NATO’s recalibration toward greater emphasis on civil preparedness and resilience alongside conventional military strength. Rather than viewing borderlands as vulnerable peripheries requiring protection, this work demonstrates how regions sharing direct frontiers with Russia have emerged as critical centres of security innovation whose proximity to threat vectors grants them unique experiential knowledge and adaptive capabilities essential for broader Alliance security. Borderland communities have developed sophisticated approaches to managing hybrid threats through whole-of-society defence models that integrate civilian and military efforts while maintaining democratic governance under pressure. Their lived experience with Russian aggression has produced practical knowledge about deterrence implementation, early warning systems, and cross-domain threat management that complements theoretical strategic planning with operational reality. The volume argues that resilience should be conceptualised not merely as recovery from disruption but as transformative capacity enabling systems to reorganise, innovate, and evolve in response to changing threat environments, positioning these borderlands as force multipliers within NATO’s deterrence framework
Carbon dioxide utilization and storage through mineralization under European Union law: a legal analysis of the EU CCS Directive and the EU Emissions Trading System
Carbon dioxide mineralization—where captured CO2 is chemically converted into stable carbonates—offers a promising pathway for permanent sequestration and low-carbon material production. Situated between Carbon Capture and Storage (CCS) and Carbon Capture and Utilization (CCU), it challenges traditional legal distinctions while aligning with European Union (EU) objectives of climate neutrality by 2050. Yet, the EU regulatory framework has historically sidelined mineralization, focusing instead on geological storage. This article analyses the treatment of mineralization under the CCS Directive and the EU Emissions Trading System. It finds that the recent guidance by the European Commission allows the CCS Directive to cover in situ mineralization. However, for certain questions, it remains ill-adapted to the specificities of geochemical transformation, leaving uncertainties in permitting, monitoring, and liability. By contrast, recent reforms under the Emissions Trading System—particularly the Commission Delegated Regulation—explicitly recognize both calcium- and magnesium-based carbonates as valid forms of permanent storage, strengthening technological neutrality and providing clearer incentives. Through this legal analysis, the article argues that mineralization is transitioning from a regulatory lacuna to an increasingly integrated component of EU climate and energy law, but that further clarification, harmonization of measurement standards, and cross-regime coordination will be essential to unlock its full contribution to Europe’s decarbonization strategy
A Prenatal Exposure to Tobacco Smoking and Children Brain Tumors: A Systematic Literature Review
The association between low muscle mass and sarcopenic obesity, survival, and major complications in patients with advanced ovarian cancer undergoing primary cytoreductive surgery: A retrospective study
Objective
The aim of this study is to determine whether imaging-derived estimates of muscle mass or sarcopenic obesity are associated with survival and surgery-related complications in patients with advanced epithelial ovarian cancer treated with primary cytoreductive surgery (PCS).
Methods
A skeletal muscle index (SMI) was determined by normalizing the muscle area at the level of third lumbar vertebra with the patient's height. Patients with SMI 25 kg/m2 were deemed to be affected by sarcopenic obesity. The relationships between low SMI and sarcopenic obesity, 1-year, 3-year, and overall survival were studied with Cox regression and Kaplan–Meier methods. The effect of SMI and sarcopenic obesity on surgery-related major complications (Clavien–Dindo ≥ IIIB) was studied with logistic regression models.
Results
Ninety-two patients were retrospectively included, of whom 35 (38.0 %) and 12 (13.0 %) had low muscle mass or were affected by sarcopenic obesity, respectively. Among 73 (79.3 %) patients with high-grade serous OC, the 1-year survival rates were 66.7 % and 95.3 % (hazard ratio [HR] 9.19 [95 % confidence interval (CI): 1.85–45.75]) and the 3-year survival rates were 58.3 % and 68.8 % (HR 2.95 [95 % CI: 1.10–7.92]) for patients with and without sarcopenic obesity, respectively. Neither low muscle mass nor sarcopenic obesity was associated with major complications.
Conclusion
Sarcopenic obesity was a marker of poor 1-year and 3-year survival in patients with high-grade serous OC. Neither low muscle mass nor sarcopenic obesity was associated with major complications in PCS
Stakeholders’ interest in national implementation of the Directive (EU) 2021/2101 regards disclosure of income tax information
Legal conditions for the recognition of third-country carbon pricing mechanisms under the EU CBAM: the case of Russian Federation
Toward novel complementary spectroscopic and additive manufacturing methods in salivary studies
Puberty‐Promoting Treatment and Psychosocial Well‐Being in Boys With Constitutional Delay of Puberty: A Randomized Controlled Trial
Objective
In boys, constitutional delay of growth and puberty (CDGP) has been associated with diverse negative psychosocial effects. Albeit alleviating distress is one of the main reasons for inducing pubertal development, the impact of puberty-promoting treatment on psychosocial wellbeing is under-researched. Our objective was to investigate the impact of puberty-promoting therapies on the behavioural patterns as defined by the temperament characteristics emotionality, activity, and sociability (EAS) in boys with CDGP.
Design
The study is a randomized, controlled, open-label trial.
Patients
Thirty boys were randomized to receive either aromatase inhibitor letrozole (2.5 mg/day) (n = 15) or intramuscular testosterone (1 mg/kg/every 4 weeks) (n = 15) for 6 months and followed up to 12 months. To compare our results with healthy peers, an age- and postal-code matched, and a national reference population were collected.
Measurements
Temperament characteristics were evaluated with a standardized and validated questionnaire at 0-, 6-, and 12-month visits.
Results
In comparison to local peers, boys with CDGP were more withdrawn (p = 0.02) and experienced less anger (p = 0.02) and fear (p = 0.02). Compared to both local and national controls, there was a significant difference in emotionality, CDGP boys being less negatively emotional than peers (p = 0.04). Sociability was higher in the Lz-group in comparison to the T-group both after the 6-month treatment period (−0.48, 95% CI: 0.89; −0.08, p = 0.019) and at 12-month follow-up (−0.72, CI: 95%, −1.12; −0.32, p = 0.001).
Conclusion
Overall, boys with CDGP exhibited a generally docile temperament. The administration of puberty-promoting treatments did not result in any adverse psychosocial effects on the temperament characteristics assessed